The FDA grants 510(k) clearance to Bayer’s (OTCPK:BAYRY +0.1%) MEDRAD Stellant FLEX Computed Tomography (CT) Injection System with Certegra Workstation for use in Contrast Enhanced Mammography (CEM).
The company says the use of iodine-based x-ray contrast agents in CEM enables better visualization of abnormalities in breast tissue that standard mammography may miss.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.